Lv1
30 积分 2024-03-15 加入
Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders
19天前
已完结
Antibody-induced modulation and intracellular transport of CD10 and CD19 antigens in human B-cell lines: an immunofluorescence and immunoelectron microscopy study
29天前
已完结
Rewiring immunity with in vivo CAR T cell engineering
30天前
已完结
Generation of Simian-Tropic HIV-1 by Restriction Factor Evasion
1个月前
已完结
Engineering T cells in vivo to express a synthetic cytokine receptor enables preferential expansion and enrichment of anti-CD22 CAR T cells
1个月前
已完结
The landscape of genetic medicines for in vivo T cell reprogramming
1个月前
已完结
Injectable bioinstructive microfoam for rapid bedside/in vivo programming of CAR-T cells
2个月前
已完结
Kupffer cells and not liver sinusoidal endothelial cells prevent lentiviral transduction of hepatocytes
2个月前
已完结
In Vivo CAR T-Cell Therapy Spurs 100% ORR in Phase I
3个月前
已关闭
In vivo CAR-T therapy: latest updates from the 2025 ASH annual meeting
3个月前
已完结
皖公网安备34019202002308
